|
Status |
Public on Jun 04, 2020 |
Title |
A genome-wide screen identifies E2F6 as critical factor for TMZ chemoresistance in EGFRvIII expressing GBM |
Organism |
Homo sapiens |
Experiment type |
Other Expression profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
31508283 |
|
Submission date |
Apr 05, 2018 |
Last update date |
Jun 04, 2020 |
Contact name |
Kai Huang |
E-mail(s) |
huangkai@tijmu.edu.cn
|
Phone |
13752390609
|
Organization name |
tianjin medical university
|
Street address |
anshan roud
|
City |
tianjin |
ZIP/Postal code |
300054 |
Country |
China |
|
|
Platforms (3) |
|
Samples (46)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE112733 |
A genome-wide screen identifies E2F6 as critical factor for TMZ chemoresistance in EGFRvIII expressing GBM (DNA-seq) |
GSE112734 |
A genome-wide screen identifies E2F6 as critical factor for TMZ chemoresistance in EGFRvIII expressing GBM (CRISPR library RNA-seq) |
GSE112735 |
A genome-wide screen identifies E2F6 as critical factor for TMZ chemoresistance in EGFRvIII expressing GBM (EGFRvIII RNA-seq) |
|
Relations |
BioProject |
PRJNA448877 |